• Aucun résultat trouvé

[PDF] Top 20 Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.

Has 10000 "Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study." found on our website. Below are the top 20 most common "Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.".

Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.

Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.

... 2. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson ... Voir le document complet

26

Postmenopausal hormone therapy and asthma onset in the E3N cohort.

Postmenopausal hormone therapy and asthma onset in the E3N cohort.

... definition of asthma met the ATS criteria, and there was a consistent reported date of asthma onset (time of first attack between 1990 and ...asthma). Results were similar ... Voir le document complet

27

Synergism between oral estrogen therapy and cytochrome P450 3A5*1 allele on the risk of venous thromboembolism among postmenopausal women.

Synergism between oral estrogen therapy and cytochrome P450 3A5*1 allele on the risk of venous thromboembolism among postmenopausal women.

... limitation of our study is that observational studies are subject to ...bias. The validity of the ESTHER study has already been discussed (3, 4, ...In the present ... Voir le document complet

7

Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study.

Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study.

... - Cohort – Dydrogesterone - Estrogen - Hormone replacement therapy - Menopause - Progestagens - Progesterone Introduction Estrogen–progestagen postmenopausal hormone replacement ... Voir le document complet

11

Effect of physical activity on women at increased risk of breast cancer: results from the E3N cohort study.

Effect of physical activity on women at increased risk of breast cancer: results from the E3N cohort study.

... 22.0, and 24.0 kg/m 2 ), history of breast cancer in first-degree relatives (yes/no), age at menarche (cut points: 12, 13, and 14), age at first full-term pregnancy (cut points: 23, 26, and 30 ... Voir le document complet

11

Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women.

Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women.

... 50s and early 60s were at the start of their contraceptive life when OCs became readily available in the ...had the possibility of using OCs at a young age and for a long ... Voir le document complet

11

Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study.

Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study.

... Subjects The ESTHER study has been previously described ...control study of VTE performed in France between 1998 and 2006. The population consisted of ... Voir le document complet

12

Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.: Bloog group, hormone therapy and risk of venous thromboembolis

Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.: Bloog group, hormone therapy and risk of venous thromboembolis

... Our results show that non-O blood type is a VTE risk factor among postmenopausal ...those from several other studies regarding the increased VTE risk among non-O blood type ... Voir le document complet

7

Progestogens and venous thromboembolism among postmenopausal women using hormone therapy.

Progestogens and venous thromboembolism among postmenopausal women using hormone therapy.

... VTE risk did not reach the signification (Hazard ...to the other progestogens, the ESTHER (EStrogen and THromboEmbolism Risk) Study, a French case/control ... Voir le document complet

22

Hormone therapy and hemostasis among postmenopausal women: a review.

Hormone therapy and hemostasis among postmenopausal women: a review.

... types of MHT that differ according to the chemical structure, the daily doses and the route of ...administration. The characteristics of the main marketed ... Voir le document complet

30

Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) cohort.

Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) cohort.

... our study is the first to consider different types of MHT combinations on diabetes risk, several authors have reported the impact of different types of hormone ... Voir le document complet

16

en
                                                                    fr

en fr Hormonal and anthropometric factors associated with depression in postmenopausal women : results from the E3N cohort Facteurs hormonaux et anthropométriques associés à la dépression chez la femme en post-ménopause : résultats de la cohorte E3N

... équipe E3N : à Maryvonne, Lyan, Marie, Rafika et Pascale qui assurent chaque jour la réussite de cette belle aventure ; à Sophie avec qui nous avons partagé, et partagerons encore je l’espère, les moments de doute ... Voir le document complet

254

Association between Radiotherapy and Risk of Cancer Associated Venous Thromboembolism: A Sub-Analysis of the COMPASS-CAT Study

Association between Radiotherapy and Risk of Cancer Associated Venous Thromboembolism: A Sub-Analysis of the COMPASS-CAT Study

... different results in terms of the sig- nificant risk factors for development of VTE compared to the previously published data used for creation of the VTE ... Voir le document complet

11

Body mass index, change in body silhouette, and risk of asthma in the E3N cohort study.

Body mass index, change in body silhouette, and risk of asthma in the E3N cohort study.

... interpretation of our results. Participants in the E3N Cohort Study were mainly female teachers with a high level of education and health consciousness ...Analyses ... Voir le document complet

12

Body silhouette, menstrual function at adolescence and breast cancer risk in the E3N cohort study.

Body silhouette, menstrual function at adolescence and breast cancer risk in the E3N cohort study.

... on the relation between high weight at (or around) menarche and risk (Le Marchand et al, 1988; Franceschi et al, 1996; Hu et al, 1997; Magnusson et al, 1998; Coates et al, 1999; Alghren et al, 2004; ... Voir le document complet

10

Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women.

Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women.

... requesting the addresses of their physicians and permission to contact ...in the cohort were detected from reports by family members or by the postal service and by ... Voir le document complet

8

Epidemiology of venous thromboembolism after lower limb arthroplasty: the FOTO study.

Epidemiology of venous thromboembolism after lower limb arthroplasty: the FOTO study.

... number of patients would not be evaluable, the recruitment target was 2000 ...to the French Program of Medicalisation of Information Systems (Programme de Médicalisation des Systèmes ... Voir le document complet

27

Incidence, risk factors, and outcomes of central venous catheter-related thromboembolism in breast cancer patients: the CAVECCAS study

Incidence, risk factors, and outcomes of central venous catheter-related thromboembolism in breast cancer patients: the CAVECCAS study

... 25% of women cancers, is the most frequent cancer and the leading cause of death in the female population worldwide ...increased risk of venous ... Voir le document complet

14

Red and processed meat intake and cancer risk: Results from the prospective NutriNet-Santé cohort study

Red and processed meat intake and cancer risk: Results from the prospective NutriNet-Santé cohort study

... INTRODUCTION The International Agency for Research on Cancer (WHO-IARC) recently classified consumption of processed meat as “carcinogenic to humans” and consumption of red meat as “probably ... Voir le document complet

22

Estimated dietary dioxin exposure and breast cancer risk among women from the French E3N prospective cohort.

Estimated dietary dioxin exposure and breast cancer risk among women from the French E3N prospective cohort.

... lower risk of ER-/PR- breast cancer in women with serum levels of PCBs in the highest tertile compared to the lowest ...cancer risk in relation to dioxin exposure also suggested ... Voir le document complet

11

Show all 10000 documents...